| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3733118
[patent_doc_number] => 05693764
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-02
[patent_title] => 'Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics'
[patent_app_type] => 1
[patent_app_number] => 8/634225
[patent_app_country] => US
[patent_app_date] => 1996-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 10497
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/693/05693764.pdf
[firstpage_image] =>[orig_patent_app_number] => 634225
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/634225 | Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics | Apr 17, 1996 | Issued |
| 08/633840 | COMPOUNDS AND METHODS FOR IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PROSTATE CANCER | Apr 10, 1996 | Abandoned |
Array
(
[id] => 3745105
[patent_doc_number] => 05801226
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Oral care compositions'
[patent_app_type] => 1
[patent_app_number] => 8/628412
[patent_app_country] => US
[patent_app_date] => 1996-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5415
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801226.pdf
[firstpage_image] =>[orig_patent_app_number] => 628412
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/628412 | Oral care compositions | Apr 4, 1996 | Issued |
| 08/609533 | USE OF DELTA-LIKE KINASE TO INHIBIT THE RATE OF DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS | Feb 29, 1996 | Abandoned |
Array
(
[id] => 4077029
[patent_doc_number] => 05965710
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer'
[patent_app_type] => 1
[patent_app_number] => 8/602725
[patent_app_country] => US
[patent_app_date] => 1996-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 19978
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965710.pdf
[firstpage_image] =>[orig_patent_app_number] => 602725
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/602725 | Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer | Feb 22, 1996 | Issued |
Array
(
[id] => 3759149
[patent_doc_number] => 05741648
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Cell analysis method using quantitative fluorescence image analysis'
[patent_app_type] => 1
[patent_app_number] => 8/605342
[patent_app_country] => US
[patent_app_date] => 1996-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 31
[patent_no_of_words] => 23384
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741648.pdf
[firstpage_image] =>[orig_patent_app_number] => 605342
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/605342 | Cell analysis method using quantitative fluorescence image analysis | Feb 8, 1996 | Issued |
Array
(
[id] => 3802874
[patent_doc_number] => 05830672
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Elisa kit for the rapid determination of N-acetyltransferase (NAT2) phenotypes'
[patent_app_type] => 1
[patent_app_number] => 8/594934
[patent_app_country] => US
[patent_app_date] => 1996-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9102
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/830/05830672.pdf
[firstpage_image] =>[orig_patent_app_number] => 594934
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/594934 | Elisa kit for the rapid determination of N-acetyltransferase (NAT2) phenotypes | Jan 30, 1996 | Issued |
Array
(
[id] => 3884106
[patent_doc_number] => 05798447
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-25
[patent_title] => 'Antibodies specific for D-myo-inositol 1, 4, 5-trisphosphate and the enzyme-linked immunosorbent assay of D-myo-inositol 1, 4, 5-trisphosphate'
[patent_app_type] => 1
[patent_app_number] => 8/584095
[patent_app_country] => US
[patent_app_date] => 1996-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5710
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/798/05798447.pdf
[firstpage_image] =>[orig_patent_app_number] => 584095
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/584095 | Antibodies specific for D-myo-inositol 1, 4, 5-trisphosphate and the enzyme-linked immunosorbent assay of D-myo-inositol 1, 4, 5-trisphosphate | Jan 10, 1996 | Issued |
Array
(
[id] => 3811840
[patent_doc_number] => 05789185
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Selective immunoassay for IL-1.beta.'
[patent_app_type] => 1
[patent_app_number] => 8/570074
[patent_app_country] => US
[patent_app_date] => 1995-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6822
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/789/05789185.pdf
[firstpage_image] =>[orig_patent_app_number] => 570074
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/570074 | Selective immunoassay for IL-1.beta. | Dec 10, 1995 | Issued |
Array
(
[id] => 4029374
[patent_doc_number] => 05855887
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Blockade of lymphocyte down-regulation associated with CTLA-4 signaling'
[patent_app_type] => 1
[patent_app_number] => 8/566853
[patent_app_country] => US
[patent_app_date] => 1995-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 13633
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/855/05855887.pdf
[firstpage_image] =>[orig_patent_app_number] => 566853
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/566853 | Blockade of lymphocyte down-regulation associated with CTLA-4 signaling | Dec 3, 1995 | Issued |
Array
(
[id] => 3935780
[patent_doc_number] => 05981237
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Method for liquefaction of cereal grain starch substrate and apparatus therefor'
[patent_app_type] => 1
[patent_app_number] => 8/565086
[patent_app_country] => US
[patent_app_date] => 1995-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 2760
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981237.pdf
[firstpage_image] =>[orig_patent_app_number] => 565086
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/565086 | Method for liquefaction of cereal grain starch substrate and apparatus therefor | Nov 29, 1995 | Issued |
Array
(
[id] => 3741539
[patent_doc_number] => 05801002
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis'
[patent_app_type] => 1
[patent_app_number] => 8/562311
[patent_app_country] => US
[patent_app_date] => 1995-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 7681
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/801/05801002.pdf
[firstpage_image] =>[orig_patent_app_number] => 562311
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/562311 | Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis | Nov 21, 1995 | Issued |
Array
(
[id] => 4008059
[patent_doc_number] => 05962331
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Cell growth regulator'
[patent_app_type] => 1
[patent_app_number] => 8/531783
[patent_app_country] => US
[patent_app_date] => 1995-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 32
[patent_no_of_words] => 12254
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962331.pdf
[firstpage_image] =>[orig_patent_app_number] => 531783
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/531783 | Cell growth regulator | Sep 20, 1995 | Issued |
Array
(
[id] => 3657688
[patent_doc_number] => 05591648
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-01-07
[patent_title] => 'Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them'
[patent_app_type] => 1
[patent_app_number] => 8/518173
[patent_app_country] => US
[patent_app_date] => 1995-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 12815
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/591/05591648.pdf
[firstpage_image] =>[orig_patent_app_number] => 518173
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/518173 | Antibodies for mevalonic acid and methods for immunological determination of mevalonic acid by using them | Aug 22, 1995 | Issued |
Array
(
[id] => 3659263
[patent_doc_number] => 05648224
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Method of determining the risk of breast cancer development'
[patent_app_type] => 1
[patent_app_number] => 8/515146
[patent_app_country] => US
[patent_app_date] => 1995-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2901
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648224.pdf
[firstpage_image] =>[orig_patent_app_number] => 515146
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/515146 | Method of determining the risk of breast cancer development | Aug 14, 1995 | Issued |
Array
(
[id] => 3807004
[patent_doc_number] => 05811268
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-22
[patent_title] => 'Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids'
[patent_app_type] => 1
[patent_app_number] => 8/512930
[patent_app_country] => US
[patent_app_date] => 1995-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10984
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/811/05811268.pdf
[firstpage_image] =>[orig_patent_app_number] => 512930
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/512930 | Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids | Aug 8, 1995 | Issued |
Array
(
[id] => 3853068
[patent_doc_number] => 05767249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'Monoclonal antibodies against type I phospholipase A.sub.2 as a diagnostic and anti-inflammatory therapeutic agent'
[patent_app_type] => 1
[patent_app_number] => 8/512509
[patent_app_country] => US
[patent_app_date] => 1995-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3821
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767249.pdf
[firstpage_image] =>[orig_patent_app_number] => 512509
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/512509 | Monoclonal antibodies against type I phospholipase A.sub.2 as a diagnostic and anti-inflammatory therapeutic agent | Aug 7, 1995 | Issued |
Array
(
[id] => 3860482
[patent_doc_number] => 05795785
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Method for the diagnosis of human malignant tumors'
[patent_app_type] => 1
[patent_app_number] => 8/454208
[patent_app_country] => US
[patent_app_date] => 1995-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2840
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795785.pdf
[firstpage_image] =>[orig_patent_app_number] => 454208
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454208 | Method for the diagnosis of human malignant tumors | Aug 6, 1995 | Issued |
Array
(
[id] => 3808565
[patent_doc_number] => 05788963
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy'
[patent_app_type] => 1
[patent_app_number] => 8/509254
[patent_app_country] => US
[patent_app_date] => 1995-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10549
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/788/05788963.pdf
[firstpage_image] =>[orig_patent_app_number] => 509254
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/509254 | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy | Jul 30, 1995 | Issued |
Array
(
[id] => 3936640
[patent_doc_number] => 05871941
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-16
[patent_title] => 'Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer'
[patent_app_type] => 1
[patent_app_number] => 8/508908
[patent_app_country] => US
[patent_app_date] => 1995-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 5163
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/871/05871941.pdf
[firstpage_image] =>[orig_patent_app_number] => 508908
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/508908 | Method of testing expression of CA125 antigen in cultured ovarian surface epithelial cells to identify and monitor individuals having a predisposition to develop ovarian cancer | Jul 27, 1995 | Issued |